B2M and cancer: We observed an upregulation of β2-microglobulin (B2M) expression in those cancer-cell-intrinsic inflammatory tumor subclusters (clusters with top inflammation score) vs. those with the lowest scores (log2FC = 0.91; Fig. 2h).